SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
SEC Accession No. 0001104659-23-040216
Filing Date
2023-03-31
Accepted
2023-03-31 16:26:03
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-03-31

Document Format Files

Seq Description Document Type Size
1 NT 10-K tm2311174d1_nt10k.htm NT 10-K 23161
  Complete submission text file 0001104659-23-040216.txt   24302
Mailing Address 414 COMMERCE DRIVE STE 120 FORT WASHINGTON PA 19034
Business Address 25-28 NORTH WALL QUAY DUBLIN L2 D01 H104 (610) 816-6640
Nabriva Therapeutics plc (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: NT 10-K | Act: 34 | File No.: 001-37558 | Film No.: 23788141
SIC: 2834 Pharmaceutical Preparations